We are live on ! Find out more
ASMB icon

Assembly Biosciences
ASMB

24 hedge funds and large institutions have $8.61M invested in Assembly Biosciences in 2024 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 9 increasing their positions, 10 reducing their positions, and 20 closing their positions.

New
Increased
Maintained
Reduced
Closed

21% more capital invested

Capital invested by funds: $7.12M → $8.61M (+$1.49M)

10.71% more ownership

Funds ownership: 1.1% → 11.81% (+11%)

10% less repeat investments, than reductions

Existing positions increased: 9 | Existing positions reduced: 10

45% less funds holding

Funds holding: 44 → 24 (-20)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 20

Holders
24
Holders Change
-20
Holders Change %
-45.45%
% of All Funds
0.35%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
9
Reduced
10
Closed
20
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
AI
Acuitas Investments
Washington
+$322K
2
MAM
Marquette Asset Management
Minnesota
+$52.2K
3
Millennium Management
Millennium Management
New York
+$47.6K
4
Renaissance Technologies
Renaissance Technologies
New York
+$41.8K
5
Vanguard Group
Vanguard Group
Pennsylvania
+$16.8K

Top Sellers

1
AFM
Anson Funds Management
Texas
-$590K
2
Two Sigma Investments
Two Sigma Investments
New York
-$111K
3
Citadel Advisors
Citadel Advisors
Florida
-$102K
4
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$58.9K
5
Franklin Resources
Franklin Resources
California
-$53.6K
Name Holding Trade Value Shares
Change 		Change in
Stake
Two Sigma Investments
26
Two Sigma Investments
New York
– -$111K -11,254 Closed
Citadel Advisors
27
Citadel Advisors
Florida
– -$102K -10,410 Closed
Susquehanna International Group
28
Susquehanna International Group
Pennsylvania
– -$58.9K -5,981 Closed
Franklin Resources
29
Franklin Resources
California
– -$53.6K -5,449 Closed
Jane Street
30
Jane Street
New York
– -$36.8K -3,742 Closed
XT
31
XTX Topco
Cayman Islands
– -$34K -3,454 Closed
Two Sigma Advisers
32
Two Sigma Advisers
New York
– -$27.2K -2,767 Closed
Charles Schwab
33
Charles Schwab
California
– -$26.6K -2,704 Closed
HF
34
HRT Financial
New York
– -$25K -2,543 Closed
Commonwealth Equity Services
35
Commonwealth Equity Services
Massachusetts
– -$14K -1,385 Closed
Bank of New York Mellon
36
Bank of New York Mellon
New York
– -$13K -1,322 Closed
RC
37
RBF Capital
California
– -$12.1K -1,228 Closed
HSBC Holdings
38
HSBC Holdings
United Kingdom
– -$9.42K -951 Closed
PWM
39
Palumbo Wealth Management
New York
– -$8.26K -840 Closed
EGM
40
Engineers Gate Manager
New York
– -$8.26K -839 Closed
SSG
41
Summit Securities Group
New York
– -$4K -417 Closed
BNP Paribas Financial Markets
42
BNP Paribas Financial Markets
France
– -$26 -3 Closed
Bank of America
43
Bank of America
North Carolina
– -$24 -2 Closed
ASN
44
Advisory Services Network
Georgia
– -$1 – –
1
2

ASMB Hedge Fund Activity: Q1 2024 in Review

24 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in Assembly Biosciences (ASMB) for Q1 2024, worth a combined $8.61M — up 21% from $7.12M a quarter earlier.

Sellers outnumbered buyers: 20 funds closed out of ASMB and 0 opened new positions — a net loss of 20 holders — while 10 trimmed existing stakes and 9 added.

The largest buyer was Acuitas Investments, adding an estimated $322K. The largest seller was Anson Funds Management, exiting entirely with an estimated $590K sold.

  • 24 institutional investors held Assembly Biosciences (ASMB) as of Q1 2024, down from 44 in Q4 2023.
  • Funds reported $8.61M of Assembly Biosciences stock for Q1 2024, up 21% quarter-over-quarter.
  • 0 funds opened new Assembly Biosciences positions in Q1 2024 and 20 closed out, a net change of -20 holders.
  • The largest Assembly Biosciences buyer in Q1 2024 was Acuitas Investments, an estimated $322K added.
  • The largest Assembly Biosciences seller in Q1 2024 was Anson Funds Management, an estimated $590K sold.

Based on aggregated 13F filings for Q1 2024.